Ain Shams University Clinical Oncology Conference Agenda

TIME

27 November

27 November

28 November

28 November

HALL A

HALL B

HALL A

HALL B

9:00-9:30

Registration

9:30-10:00

Opening Ceremony

10:00-10:30

Management of HCC in Late Child A / early CHILD

B: Benefit, toxicities

10:30-11:00

Chemotherapy in Hepatitis patients: the challenges

11:00-11:30

Hepatic surgery in HCC: Resection and liver

transplantation timing

11:30-12:00
12:00-12:30
12:30-1:00

1:00-1:30

Break

Break

New therapeutics in
advanced stage gastric
carcinomas
Management of gastric
lymphoma
Management of
Imatinib resistant GIST:
Therapeutics and
surgical options

Therapeutic options in
metastatic renal cell
carcinoma
Neo-adjuvant therapy
for RCC: is there a role?
Pancreatico-biliary
surgery

1:30 2:00
SYMPOSIUM
2:00 2:30

Egyptian statistics and situation

Risk factors and
Screening of
mesothelioma in Egypt

Management of muscle
invasive bladder cancer

Evolving role of systemic

therapy in mesothelioma
Surgery for
mesothelioma: Timing
and new modalities

Should we treat SCC and

adenocarcinoma of the
bladder differently?
The role of targeted
therapy and PRRT in
pancreatic NET

Prayer time
And
Break

New trends in castration

resistant prostate cancer
Hypo-fractionation in
localized prostate
cancer: toxicity and
efficacy
Intermittent ADT in
Metastatic prostate
cancer

Surgical milestones in
limited stage SCLC
Immunotherapy in
NSCLC
Optimizing treatment in
lung neuro-endocrinal
tumors

2:30-3:00
LUNCH

SYMPOSIUM(2.5-3.5)

3:00-3:30

3:30-4:00

Molecular
pathogenesis of
Colorectal cancer

Novel modalities in
NSCLC radiotherapy
(IMRT, 3DCRT,
Stereotaxy)

4:00-4:30

Fertility issues in rectal

cancer patients.

Molecular analysis in
management of NSCLC:
when and for whom?

4:30-5:00

Adjuvant systemic
therapy in colorectal
cancer patients with
MMR defects

Maintenance systemic
therapy in NSCLC: is it
debatable?

5:00-5:30

Controversies in
hepatic resection for
colorectal metastasis

Surgery for mediastinal

Lymph node positive
NSCLC

5:30-6:30

Break

6:30 7:30

Symposium

LUNCH(3.5-4.5)
Adjuvant therapy after
neoadjuvant treatment
and resection of rectal
cancers
Multi-institutional
experience for
borderline resectable
hepatic metastasis from
colorectal cancer
What's beyond 1st line in
metastatic CRC

Screening of prostate
cancer: is it worth
debating in North
African patients
Prostate cancer
radiotherapy: dose
escalation; how and
why?
Management of ADT
adverse events
(andropause)

BREAK
HEALTH ECONOMIC RESULTS

7:30-9:00

REWARDS ----- Closing ceremony

9:00 10:00

Gala Dinner

HALL C (BY RESERVATION)

THURSDAY: HEALTH ECONOMICS EXPERT FORUM
1- Guidelines development for management of cancer patients in developing countries
2- National policies for adoption of novel therapeutics in Egyptian Oncology practice
3- Cost of palliative care: alternative options
4- Opportunities for cost-effectiveness research
FRIDAY: ADVANCED RADIATION WORKSHOP
1.
2.
3.
4.
5.
6.
7.

New modalities in radiation oncology

Imaging techniques in radiotherapy
Controversies in contouring guidelines
Tolerance doses in non-conventional radiotherapy techniques
Quality assurance in radiotherapy
Medical Physics and its contribution to radiotherapy research
Updates in radiotherapy trials